The counteradhesive proteins, thrombospondin 1 and SPARC/osteonectin, open the tyrosine phosphorylation-responsive paracellular pathway in pulmonary vascular endothelia

Microvascular Research

Volumn 77, Issue 1, 2009, Pages 13-20

  Liu, Anguo ^a   Mosher, Deane F ^b   Murphy Ullrich, Joanne E ^c   Goldblum, Simeon E ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

Catenins; Counteradhesive proteins; Epidermal growth factor receptor; Paracellular pathway; Protein tyrosine phosphatase mu; SPARC Osteonectin; Thrombospondin 1; Tyrosine phosphorylation; Vascular endothelial cadherin; Zonula adherens

Indexed keywords

ANGIOPOIETIN; BRADYKININ; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HYDROGEN PEROXIDE; OSTEONECTIN; PROTEIN TYROSINE PHOSPHATASE; TENASCIN; THROMBIN; THROMBOCYTE ACTIVATING FACTOR; THROMBOSPONDIN 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD VESSEL PERMEABILITY; CELL ADHESION; CELL INTERACTION; ENDOTHELIUM; EXTRACELLULAR MATRIX; HUMAN; LUNG BLOOD VESSEL; LUNG INJURY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ANIMALS; CAPILLARY PERMEABILITY; ENDOTHELIUM, VASCULAR; HUMANS; LUNG; OSTEONECTIN; PHOSPHOTYROSINE; RECEPTOR, ERBB-2; SIGNAL TRANSDUCTION; THROMBOSPONDIN 1;

EID: 59849120828     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2008.08.008     Document Type: Article

References (134)

1. Adams J.C. Thrombospondins: multifunctional regulators of cell interactions. Annu. Rev. Cell Dev. Biol. 17 (2001) 25-51
2. Adams J., and Lawler J. The thrombospondin family. Curr. Biol. 3 (1993) 188-190 1993
3. Adams J.C., Kureishy N., and Taylor A.L. A role for syndecan-1 in coupling fascin spike formation by thrombospondin-1. J. Cell Biol. 152 (2001) 1169-1182
4. Adomeit A., Graness A., Gross S., Seedorf K., Wetzker R., and Liebmann C. Bradykinin B(2) receptor-mediated mitogen-activated protein kinase activation in COS-7 cells requires dual signaling via both protein kinase C pathway and epidermal growth factor receptor transactivation. Mol. Cell. Biol. 19 (1999) 5289-5297
5. Anglin, I.E., Hyun, S.W., Yang, S., Passaniti, A., Goldblum, S.E., 2007. Receptor protein tyrosine phosphatase-μ is a negative regulator of epidermal growth factor-mediated migration in human lung alveolar epithelial cells. 47th Am. Soc. Cell Biol. Annu. Mtg. Abstr. No. 2273, pg 166.
6. Apella E., Weber I.T., and Blasi F. Structure and function of epidermal growth factor-like regions in proteins. FEBS Lett. 231 (1988) 1-4
7. Asano K., Nakamura H., Lilly C.M., Klagsbrun M., and Drazen J.M. Interferon g induces prostaglandin G/H synthase-2 through an autocrine loop via the epidermal growth factor in human bronchial epithelial cells. J. Clin. Invest. 99 (1997) 1057-1063
8. Asch A.S., Silbieger S., Heimer E., and Nachman R.L. Thrombospondin sequence motif (CSVTCG) is responsible for CD36 binding. Biochem. Biophys. Res. Commu. 182 (1992) 1208-1217
9. Ayalon O., and Geiger B. Cyclic changes in the organization of cell adhesions and the associated cytoskeleton, induced by stimulation of tyrosine phosphorylation in bovine aortic endothelial cells. J. Cell Sci. 110 (1997) 547-556
10. Baenziger N.L., Brodie G.N., and Majerus P.W. A thrombin-sensitive protein of human platelet membranes. Proc. Natl. Acad. Sci. U. S. A. 68 (1971) 240-243
11. Bhattacharyya S., Marinic T.E., Krukovets I., Hoppe G., and Stenina O.I. Cell type-specific post-transcriptional regulation of production of the potent antiangiogenic and proatherogenic protein thrombospondin-1 by high glucose. J. Biol. Chem. 283 (2008) 5699-5707
12. Bannerman D.D., and Goldblum S.E. Endotoxin induces endothelial barrier dysfunction through protein tyrosine phosphorylation. Am. J. Physiol. 273 (1997) L217-L226
13. Bonnefoy A., Moura R., and Hoylaerts M.F. The evolving role of thrombospondin-1 in hemostasis and vascular biology. Cell. Mol. Life Sci. 65 (2008) 713-727
14. Bornstein P. Thrombospondins: structure and regulation of expression. FASEB J. 6 (1992) 3290-3299
15. Bornstein P. Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1. J. Cell Biol. 130 (1995) 503-506
16. Bornstein P. Thrombospondins as matricellular modulators of cell function. J. Clin. Invest. 107 (2001) 929-934
17. Bornstein P., and Sage E.H. Thrombospondins. Methods Enzymol. 245 (1995) 62-85
18. Botney M.D., Kaiser L.R., Cooper J.D., Mecham R.P., Parghi D., Roby J., and Par W.C. Extracellular matrix protein gene expression in atherosclerotic hypertensive pulmonary arteries. Am. J. Pathol. 140 (1992) 357-364
19. Bowers G., Reardon D., Hewitt T., Dent P., Mikkelsen R.B., Valerie K., Lammering G., Amir C., and Schmidt-Ullrich R.K. The relative role of ErbB1-4 receptor tyrosine kinases in radiation signal transduction responses of human carcinoma cells. Oncogene 20 (2001) 1388-1397
20. Brittain H.A., Eckman J.R., and Swerlick R.A. Thrombospondin from activated platelets promotes sickle erythrocyte adherence to human microvascular endothelium under physiologic flow: a potential role for platelet activation in sickle cell vaso-occlusion. Blood 81 (1993) 2137-2143
21. 1 integrin binding sites in the type 1 and type 2 repeats of thrombospondin 1. J. Biol. Chem. 279 (2004) 41734-41743
22. Carlson C.B., Bernstein D.A., Annis D.S., Misenheimer T.M., Hannah B.L., Mosher D.F., and Keck J.L. Structure of the calcium-rich signature domain of human thrombospondin-2. Nat. Struct. Mol. Biol. 12 (2005) 910-914
23. Carlson C.B., Lawler J., and Mosher D.F. Structures of thrombospondins. Cell. Mol. Life Sci. 65 (2008) 672-686
24. Carpenter G. Employment of the epidermal growth factor receptor in growth factor-independent signaling pathways. J. Cell Biol. 146 (1999) 697-702
25. Chen J., Somanath P.R., Razorenova O., Chen W.S., Hay N., Bornstein P., and Byzova T.V. Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo. Nat. Med. 11 (2005) 1188-1196
26. Chesnutt A.N., Kheradmand F., Folkesson H.G., Alberts M., and Matthay M.A. Soluble transforming growth factor-α is present in the pulmonary edema fluid of patients with acute lung injury. Chest 111 (1997) 652-656
27. Chiquet-Ehrismann R. Anti-adhesive molecules of the extracellular matrix. Curr. Opin. Cell Biol. 3 (1991) 800-804
28. Chiquet-Ehrismann R. Inhibition of cell adhesion by anti-adhesive molecules. Curr. Opin. Cell Biol. 7 (1995) 715-719
29. Chiquet-Ehrismann R. Tenascins. Int. J. Biochem. Cell Biol. 36 (2004) 986-990
30. Chiquet-Ehrismann R., and Chiquet M. Tenascins: regulation and putative functions during pathological stress. J. Pathol. 200 (2003) 488-499
31. Cooke B.M., Berendt A.R., Craig A.G., MacGregor J., Newbold C.I., and Nash G.B. Rolling and stationary cytoadhesion of red blood cells parasitized by Plasmodium falciparum: separate roles for ICAM-1, CD36 and thrombospondin. Br. J. Haematol. 87 (1994) 162-170
32. Dawes J., Clemetson K.J., Gogstad G.O., McGregor J., Clezardin P., Prowse C.V., and Pepper D.S. A radioimmunoassay for thrombospondin, used in a comparative study of thrombospondin, beta-thromboglobulin and platelet factor 4 in healthy volunteers. Thromb. Res. 29 (1983) 569-581
33. Deb T.B., Wong L., Salomon D.S., Zhou G., Dixon J.E., Gutkind J.S., Thompson S.A., and Johnson G.R. A common requirement for the catalytic activity and both SH2 domains of SHP-2 in mitogen-activated protein (MAP) kinase activation by the ErbB family of receptors. A specific role for SHP-2 in map, but not c-Jun amino-terminal kinase activation. J. Biol. Chem. 273 (1998) 16643-16646
34. Donato N.J., Gallick G.E., Steck P.A., and Rosenblum M.G. Tumor necrosis factor modulates epidermal growth factor receptor phosphorylation and kinase activity in human tumor cells. J. Biol. Chem. 264 (1989) 20474-20481
35. Donnini S., Morbidelli L., Taraboletti G., and Ziche M. ERK1-2 and p38 MAPK regulate MMP/TIMP balance and function in response to thrombospondin-1 fragments in the microvascular endothelium. Life Sci. 74 (2004) 2975-2985
36. Engel J. EGF-like domains in extracellular matrix proteins: localized signals for growth and differentiation?. FEBS Lett. 251 (1989) 1-7
37. Erickson H.P. Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions. Curr. Opin. Cell Biol. 5 (1993) 869-876
38. Erickson H.P., and Bourdon M.A. Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors. Annu. Rev. Cell Biol. 5 (1989) 71-92
39. Esser S., Lampugnani M.G., Corada M., Dejana E., and Risau W. Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. J. Cell Sci. 111 (1998) 1853-1865
40. Favier J., Germain S., Emmerich J., Corvol P., and Gasc J.M. Critical overexpression of thrombospondin 1 in chronic leg ischaemia. J. Pathol. 207 (2005) 358-366
41. Frazier W.A. Thrombospondin: a modular adhesive glycoprotein of platelets and nucleated cells. J. Cell Biol. 105 (1995) 625-632
42. Gao A.-G., Lindberg F.P., Finn M.B., Blystone S.D., Brown E.J., and Frazier W.A. Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin. J Biol Chem 271 (1996) 21-24 1996
43. Gao A.G., Lindberg F.P., Dimitry J.M., Brown E.J., and Frazier W.A. Thrombospondin modulates alpha v beta 3 function through integrin-associated protein. J. Cell Biol. 135 (1996) 533-544
44. Gao L., Qiu W., Wang Y., Xu W., Xu J., and Tong J. Sublytic complement C5b-9 complexes induce thrombospondin-1 production in rat glomerular mesangial cells via PI3-k/Akt: association with activation of latent transforming growth factor-beta1. Clin. Exp. Immunol. 144 (2006) 326-334
45. Garg, P., Yang, S., Liu, A., Annis, D.S., Pallero, M.A., Passaniti, A., Mosher, D.F., Murphy-Ullrich, J., Goldblum, S.E., 2007. Thrombospondin (TSP)1 increases tyrosine phosphorylation of zonula adherens (ZA) proteins and regulates the endothelial paracellular pathway through epidermal growth factor receptor (EGFR) activation. 47th Am. Soc. Cell Biol. Annu. Mtg. Abstr No. 338, pg 64.
46. Gebb S., and Stevens T. On lung endothelial cell heterogeneity. Microvasc. Res. 68 (2004) 1-12 2004
47. Goicoechea S., Orr A.W., Pallero M.A., Eggleton P., and Murphy-Ullrich J.E. Thrombospondin mediates focal adhesion disassembly through interactions with cell surface calreticulin. J. Biol. Chem. 275 (2000) 36358-36368
48. Goicoechea S., Pallero M.A., Eggleton P., Michalak M., and Murphy-Ullrich J.E. The anti-adhesive activity of thrombospondin is mediated by the N-terminal domain of cell surface calreticulin. J. Biol. Chem. 277 (2002) 37219-37228
49. Goldblum S.E., Ding X., Funk S.E., and Sage E.H. SPARC (secreted protein acidic and rich in cysteine) regulates endothelial cell shape and barrier function. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 3448-3452
50. Goldblum S.E., Young B.A., Wang P., and Murphy-Ullrich J.E. Thrombospondin-1 induces tyrosine phosphorylation of adherens junction proteins and regulates an endothelial paracellular pathway. Mol. Biol. Cell 10 (1999) 1537-1551
51. Greenwalt D.E., Lipsky R.H., Ockenhouse C.F., Ikeda H., Tandon N.N., and Jamieson G.A. Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction, and transfusion medicine. Blood 80 (1992) 1105-1115
52. Hackel P.O., Zwick E., Prenzel N., and Ullrich A. Epidermal growth factor receptors: critical mediators of multiple receptor pathways. Curr. Opin. Cell Biol. 11 (1999) 184-189 1999
53. Hamaguchi M., Matsuyoshi N., Ohnishi Y., Gotoh B., Takeichi M., and Nagai Y. p60v-src causes tyrosine phosphorylation and inactivation of the N-cadherin-catenin cell adhesion system. EMBO J. 12 (1993) 307-314
54. Hasselaar P., and Sage E.H. SPARC antagonizes the effect of basic fibroblast growth factor on the migration of bovine aortic endothelial cells. J. Cell. Biochem. 49 (1992) 272-283
55. Holmes D.I., Wahab N.A., and Mason R.M. Identification of glucose-regulated genes in human mesangial cells by mRNA differential display. Biochem. Biophys. Res. Commun. 1997 (1997) 179-184
56. Hoschuetzky H., Aberle H., and Kemler R. β-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor. J. Cell Biol. 127 (1994) 1375-1380
57. Hsia H.C., and Schwarzbauer J.E. Meet the tenascins: multifunctional and mysterious. J. Biol. Chem. 280 (2005) 26641-26644
58. Huang R.-P., Wu J.-X., Fan Y., and Adamson E.D. UV activates growth factor receptors via reactive oxygen intermediates. J. Cell Biol. 133 (1996) 211-220
59. Ide M., Ishii H., Mukae H., Iwata A., Sakamoto N., Kadota J.I., and Kohno S. High serum levels of thrombospondin-1 in patients with idiopathic interstitial pneumonia. Respir. Med. (2008) [Electronic publication ahead of print]
60. Idell S., Maunder R., Fein A.M., Switalska H.I., Tuszynski G.P., McLarty J., and Niewiarowski S. Platelet-specific α-granule proteins and thrombospondin in bronchoalveolar lavage in the adult respiratory distress syndrome. Chest 96 (1989) 1125-1132
61. Iozzo R.V., Moscatello D.K., McQuillan D.J., and Eichstetter I. Decorin is a biological ligand for the epidermal growth factor receptor. J. Biol. Chem. 274 (1999) 4489-4492
62. Iruela-Arispe M.L., Hasselaar P., and Sage H. Differential expression of extracellular proteins is correlated with angiogenesis in vitro. Lab. Invest. 64 (1991) 174-186
63. Iruela-Arispe M.L., Diglio C.A., and Sage E.H. Modulation of extracellular matrix proteins by endothelial cells undergoing angiogenesis in vitro. Arterioscler. Thromb. 11 (1991) 805-815
64. Jaffe E.A., Ruggiero J.T., and Falcone D.J. Monocytes and macrophages synthesize and secrete thrombospondin. Blood 65 (1985) 79-84
65. Jones F.S., and Jones P.L. The tenascin family of ECM glycoproteins: structure, function, and regulation during embryonic development and tissue remodeling. Dev. Dyn. 218 (2000) 235-259
66. Kermorvant-Duchemin E., Sennlaub F., Sirinyan M., Brault S., Andelfinger G., Kooli A., Germain S., Ong H., d, Orleans-Juste P., Gobeil Jr. F., Zhu T., Boisvert C., Hardy P., Jain K., Falck J.R., Balazy M., and Chemtob S. Trans-arachidonic acids generated during nitrative stress induce a thrombospondin-1-dependent microvascular degeneration. Nat. Med. 11 (2005) 1339-1345
67. Kelly K.A., Allport J.R., Yu A.M., Sinh S., Sage E.H., Gerszten R.E., and Weissleder R. SPARC is a VCAM-1 counter-ligand that mediates leukocyte transmigration. J. Leukoc. Biol. 81 (2007) 748-756
68. Ketis N.V., Lawler J., Hoover R.L., and Karnovsky M.J. Effects of heat shock on the expression of thrombospondin by endothelial cells in culture. J. Cell Biol. 106 (1988) 893-904
69. Kreis C., La Fleur M., Menard C., Paquin R., and Beaulieu A.D. Thrombospondin and fibronectin are synthesized by neutrophils in human inflammatory joint disease and in a rabbit model of in vivo neutrophil activation. J. Immunol. 143 (1989) 1961-1968
70. Kuhn C., and Mason R.J. Immunolocalization of SPARC, tenascin, and thrombospondin in pulmonary fibrosis. Am. J. Pathol. 147 (1995) 1759-1769
71. Lahav J. The functions of thrombospondin and its involvement in physiology and pathophysiology. Biochim. Biophys. Acta 1182 (1993) 1-14
72. Lane T.F., and Sage E.H. The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB J. 8 (1994) 163-173
73. Lawler J. The structural and functional properties of thrombospondin. Blood 67 (1986) 1197-1209
74. Lawler J., Derick L.H., Connolly J.E., Chen J.-H., and Chao F.C. The structure of human platelet thrombospondin. J. Biol. Chem. 260 (1985) 3762-3772
75. Lawler J., Weinstein R., and Hynes R.O. Cell attachment to thrombospondin: the role of ARG-GLY-ASP, calcium, and integrin receptors. J. Cell Biol. 107 (1988) 2351-2361
76. Lee S.R., Kwon K.S., Kim S.R., and Rhee S.G. Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. J. Biol. Chem. 273 (1998) 15366-15372
77. Leung L.L.K. Role of thrombospondin in platelet aggregation. J. Clin. Invest. 74 (1984) 1764-1772
78. Lidington D., Tyml K., and Ouellette Y. Lipopolysaccharide-induced reductions in cellular coupling correlate with tyrosine phosphorylation of connexin 43. J. Cell. Physiol. 193 (2002) 373-379
79. 3-dependent ligand binding. J. Cell Biol. 123 (1993) 485-496
80. Liu, A., Garg, P., Yang, S., Gong, P., Annis, D.S., Pallero, M.A., Passaniti, A., Mann, D., Mosher, D.F., Murphy-Ullrich, J., Goldblum, S.E., 2007. The EGF-like repeats of thrombospondin 1 active phospholipase Cγ and increases epithelial cell migration through epidermal growth factor receptor activation. 47th Am. Soc. Cell Biol. Annu. Mtg. Abstr No. 77, pg 55.
81. Macko R.F., Gelber A.C., Young B.A., Lowitt M.H., White B., Wigley F.M., and Goldblum S.E. Increased circulating concentrations of the counteradhesive proteins SPARC and thrombospondin-1 in systemic sclerosis (scleroderma). Relationship to platelet and endothelial cell activation. J. Rheumatol. 29 (2002) 2565-2570
82. Madtes D.K., Rubenfeld G., Klima L.D., Milberg J.A., Steinberg K.P., Martin T.R., Raghu G., Hudson L.D., and Clark J.G. Elevated transforming growth factor-alpha levels in bronchoalveolar lavage fluid of patients with acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 158 (1998) 424-430
83. Malashkevich V.N., Kammerer R.A., Efimov V.P., Schulthess T., and Engel J. The crystal structure of a five-stranded coiled coil in COMP: a prototype ion channel?. Science 274 (1996) 761-765
84. Mariner D.J., Davis M.A., and Reynolds A.B. EGFR signaling to p120-catenin through phosphorylation at Y228. J. Cell Sci. 117 (2004) 1339-1350
85. Marinides G.N., Suchard S.J., and Mookerjee B.K. Role of thrombospondin in mesangial cell growth: possible existence of an autocrine feedback growth circuit. Kidney Int. 46 (1994) 350-357
86. Mikhailenko I., Kounnas M.Z., and Strickland D.K. Low density lipoprotein receptor-related protein/alpha w-macroglobulin receptor mediates the cellular internalization and degradation of thrombospondin. A process facilitated by cell-surface proteoglycans. J. Biol. Chem. 270 (1995) 9543-9549
87. Miyamoto S., Teramoto H., Gutkind J.S., and Yamada K.M. Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: roles of integrin aggregation and occupancy of receptors. J. Cell Biol. 135 (1996) 1633-1642 1996
88. Moro L., Venturino M., Bozzo C., Silengo L., Altruda F., Beguinot L., Tarone G., and Defilippi P. Integrins induce activation of EGF receptor: role in MAP kinase induction and adhesion-dependent cell. EMBO J. 17 (1998) 6622-6632
89. Mosher D.F. Physiology of thrombospondin. Annu. Rev. Med. 41 (1990) 85-97
90. Mosher D.F., Doyle M.J., and Jaffee E.A. Synthesis and secretion of thrombospondin by culture human endothelial cells. J. Cell Biol. 93 (1982) 343-348
91. Murphy-Ullrich J.E. Anti-adhesive proteins of the extracellular matrix: Thrombospondin, tenascin, and SPARC. Trends in Glycoscience and Glycotechnology vol. 7 (1995) 89-100
92. Murphy-Ullrich J.E. The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state?. J. Clin. Invest. 107 (2001) 785-790
93. Neri M., Descalzi-Cancedda F., and Cancedda R. Heat-shock response in cultured chick embryo chondrocytes. Osteonectin is a secreted heat-shock protein. Eur. J. Biochem. 205 (1992) 569-574
94. Nunes S.S., Outeiro-Bernstein M.A., Juliano L., Vardiero F., Nader H.B., Woods A., Legrand C., and Morandi V. Syndecan-4 contributes to endothelial tubulogenesis through interactions with two motifs inside the pro-angiogenic N-terminal domain of thrombospondin-1. J. Cell. Physiol. 214 (2008) 828-837
95. Orend G., and Chiquet-Ehrismann R. Tenascin-C induced signaling in cancer. Cancer Lett. 244 (2006) 143-163
96. Orr A.W., Pedraza C.E., Pallero M.A., Elzie C.A., Goicoechea S., Strickland D.K., and Murphy-Ullrich J.E. Low density lipoprotein receptor-related protein is a calreticulin coreceptor that signals focal adhesion disassembly. J. Cell Biol. 161 (2003) 1179-1189
97. Pan Z., Kravchenko V.V., and Ye R.D. Platelet-activating factor stimulates transcription of the heparin-binding epidermal growth factor-like growth factor in monocytes. J. Biol. Chem. 270 (1995) 7787-7790
98. Pece S., and Gutkind J.S. Signaling from E-cadherins to the MAPK pathway by the recruitment and activation of epidermal growth factor receptors upon cell-cell contact formation. J. Biol. Chem. 275 (2000) 41227-41233
99. Prenzel N., Zwick E., Daub H., Leserer M., Abraham R., Wallasch C., and Ullrich A. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402 (1999) 884-888
100. Qiu Y., Ravi L., and Kung H.-J. Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells. Nature 393 (1998) 83-85
101. Raines E.W., Lane T.F., Iruela-Arispe M.L., Ross R., and Sage E.H. The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 1281-1285
102. Reed M.J., Puolakkainen P., Lane T.F., Dickerson D., Bornstein P., and Sage E.H. Differential expression of SPARC and thrombospondin 1 in wound repair: immunolocalization and in situ hybridization. J. Histochem. Cytochem. 41 (1993) 1467-1477
103. Reinhold M.I., Lindberg F.P., Plas D., Reynolds S., Peters M.G., and Brown E.J. In vivo expression of alternatively spliced forms of integrin-associated protein (CD47). J. Cell Sci. 108 (1995) 3419-3425
104. Riessen R., Kearney M., Lawler J., and Isner J.M. Immunolocalization of thrombospondin-1 in human atherosclerotic and restenotic arteries. Am. Heart J. 135 (1998) 357-364
105. 2+. Biochem. Cell. Biol. 70 (1992) 56-62
106. Sage E.H., and Bornstein P. Extracellular proteins that modulate cell-matrix interactions. SPARC, tenascin, and thrombospondin. J. Biol. Chem. 266 (1991) 14831-14834
107. Sage H., Johnson C., and Bornstein P. Characterization of a novel serum albumin-binding glycoprotein secreted by endothelial cells in culture. J. Biol. Chem. 259 (1984) 3993-4007
108. Sage H., Tupper J., and Bramson R. Endothelial cell injury in vitro is associated with increased secretion of an Mr 43,000 glycoprotein ligand. J. Cell. Physiol. 127 (1986) 373-387
109. 2+-binding extracellular protein associated with endothelial cell injury and proliferation. J. Mol. Cell. Cardiol. 1 (1989) 13-22
110. +2-dependent binding to the extracellular matrix. J. Cell Biol. 109 (1989) 341-356
111. Saito Y., Haendeler J., Hajo Y., Yamamoto K., and Berk B.C. Yamamoto, K., and Berk BC. Receptor heterodimerization: Essential mechanism for platelet-derived growth factor-induced epidermal growth factor receptor transactivation. Mol. Cell. Biol. 21 (2001) 6387-6394
112. Sauk J.J., Norris K., Kerr J.M., Somerman M.J., and Young M.F. Diverse forms of stress result in changes in cellular levels of osteonectin/SPARC without altering mRNA levels in osteoligament cells. Calcif. Tissue Int. 49 (1991) 58-62
113. Schenk S., Hintermann E., Bilban M., Koshikawa N., Hojilla C., Khokha R., and Quaranta V. Binding to EGF receptor of a laminin-5 EGF-like fragment liberated during MMP-dependent mammary gland involution. J. Cell Biol. 161 (2003) 197-209
114. Sezaki S., Hirohata S., Iwabu A., Nakamura K., Toeda K., Miyoshi T., Yamawaki H., Demircan K., Kusachi S., Shiratori Y., and Ninomiya Y. Thrombospondin-1 is induced in rat myocardial infarction and its induction is accelerated by ischemia/reperfusion. Exp. Biol. Med. 230 (2005) 621-630
115. Shibamoto S., Hayakawa M., Takeuchi K., Hori T., Oku N., Miyazawa K., Kitamura N., Takeichi M., and Ito F. Tyrosine phosphorylation of β-catenin and plakoglobin enhanced by hepatocyte growth factor and epidermal growth factor in human carcinoma cells. Cell Adhes. Commun. 1 (1994) 295-305
116. Short S.M., Derrien A., Narsimhan R.P., Lawler J., Ingber D.E., and Zetter B.R. Inhibition of endothelial cell migration by thrombospondin-1 type-1 repeats is mediated by beta1 integrins. J. Cell Biol. 168 (2005) 643-653
117. Siano J.P., Grady K.K., Millet P., Swerlick R.A., and Wick T.M. Plasmodium falciparum: soluble thrombospondin increases cytoadherence of parasitized erythrocytes to human microvascular endothelium under shear flow conditions. Exp. Parasitol. 87 (1997) 69-72
118. Sid B., Sartelet H., Bellon G., El Btaouri H., Rath G., Delorme N., Haye B., and Martiny L. Thrombospondin 1: a multifunctional protein implicated in the regulation of tumor growth. Crit. Rev. Oncol./Hematol. 49 (2004) 245-258
119. Singleton P.A., Garcia J.G., and Moss J. Synergistic effects of methylnaltrexone with 5-fluorouracil and bevacizumab on inhibition of vascular endothelial growth factor-induced angiogenesis. Mol. Cancer Ther. 7 (2008) 1669-1679
120. Stenner D.D., Tracy R.P., Riggs B.L., and Mann K.G. Human platelets contain and secrete osteonectin, a major protein of mineralized bone. Proc. Natl. Acad. Sci. U. S. A. 83 (1986) 6892-6896
121. Sui X., Kiser T.D., Hyun S.W., Angelini D.J., Del Vecchio R.L., Young B.A., Hasday J.D., Romer L.H., Passaniti A., Tonks N.K., and Goldblum S.E. Receptor protein tyrosine phosphatase μ regulates the paracellular pathway in human lung microvascular endothelia. Am. J. Pathol. 166 (2005) 1247-1258
122. Swerlick R.A., Lee K.H., Wick T.M., and Lawley T.J. Human dermal microvascular endothelial but not human umbilical vein endothelial cells express CD36 in vivo and in vitro. J. Immunol. 148 (1992) 78-83
123. Swindle C.S., Tran K.T., Johnson T.D., Banerjee P., Mayes A.M., Griffith L., and Wells A. Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor. J. Cell Biol. 154 (2001) 459-468
124. Tan K., Duquette M., Liu J.H., Zhang R., Joachimiak A., Wang J.H., and Lawler J. The structures of the thrombospondin-1 N-terminal domain and its complex with a synthetic pentameric heparin. Structure 14 (2006) 33-42
125. Thakar C.V., Zahedi K., Revelo M.P., Wang Z., Burnham C.E., Barone S., Bevans S., Lentsch A.B., Rabb H., and Soleimani M. Identification of thrombospondin 1 (TSP-1) as a novel mediator of cell injury in kidney ischemia. J. Clin. Invest. 115 (2005) 3451-3459
126. Tsao P.W., and Mousa S.A. Thrombospondin mediates calcium mobilization in fibroblasts via its Arg-Gly-Asp and carboxyl-terminal domains. J. Biol. Chem. 270 (1995) 23747-23753
127. Tsukita S., Oishi K., Akiyama T., Yamanashi Y., Yamamoto T., and Tsukita S. Specific proto-oncogenic tyrosine kinases of src family are enriched in cell-to-cell adherens junctions where the level of tyrosine phosphorylation is elevated. J. Cell Biol. 113 (1991) 867-879
128. Van Itallie C.M., Balda M.S., and Anderson J.M. Epidermal growth factor induces tyrosine phosphorylation and reorganization of the tight junction protein ZO-1 in A431 cells. J. Cell Sci. 108 (1995) 1735-1742
129. Vivekananda J., Lin A., Coalson J.J., and King R.J. Acute inflammatory injury in the lung precipitated by oxidant stress induces fibroblasts to synthesize and release transforming growth factor-α. J. Biol. Chem. 269 (1994) 25057-25061
130. Wang S., Wu Z., Sorenson C.M., Lawler J., and Sheibani N. Thrombospondin-1-deficient mice exhibit increased vascular density during retinal vascular development and are less sensitive to hyperoxia-mediated vessel obliteration. Dev. Dyn. 228 (2003) 630-642
131. Yehualaeshet T., O'Connor R., Begleiter A., Murphy-Ullrich J.E., Silverstein R., and Khalil N. A CD36 synthetic peptide inhibits bleomycin-induced pulmonary inflammation and connective tissue synthesis in the rat. Am. J. Respir. Cell Mol. Biol. 23 (2000) 204-212
132. Young B.A., Wang P., and Goldblum S.E. The counteradhesive protein SPARC regulates an endothelial paracellular pathway through protein tyrosine phosphorylation. Biochem. Biophys. Res. Commun. 251 (1998) 320-327
133. Zhou Y., Hagood J.S., and Murphy-Ullrich J.E. Thy-1 expression regulates the ability of rat lung fibroblasts to activate transforming growth factor-beta in response to fibrogenic stimuli. Am. J. Pathol. 165 (2004) 659-669
134. Zhou Y., Poczatek H.H., Berecek K.H., and Murphy-Ullrich J.E. Thrombospondin 1 mediates angiotensin II induction of TGF-beta activation by cardiac and renal cells under both high and low glucose conditions. Biochem. Biophys. Res. Commun. 339 (2006) 633-641